The crypts and villi of the intestine are lined by a complex continuous single cell layer epithelium. Multipotential anchored stem cells located near the base of the crypts give rise to four terminally differentiated cell types, the majority of which migrate to the tips of the villi and are extruded within three to four days. The intestinal crypt cells represent one of the most rapidly proliferating cell populations in adult animals, with each crypt producing about 300 cells per day. The mechanisms controlling the rapid proliferation and cell differentiation in the intestine are not well understood. The family of tyrosine kinases includes a number of growth factor receptors and oncogenes, and these function to regulate growth and differentiation in a variety of systems. We hypothesize that tyrosine kinases also play an important regulatory role in the intestinal crypts. To identify the tyrosine kinase genes expressed in the crypts, we used the polymerase chain reaction primed by degenerate oligonucleotide probes corresponding to two invariant amino acid sequence motifs found in all tyrosine kinases, to amplify tyrosine kinase catalytic domains using crypt cell cDNA as a template. The amplified tyrosine kinase fragments were cloned and 285 clones have been characterized. Sequencing has identified several tyrosine kinase genes expressed in the crypts, including 14 novel genes. By examining their expression, we are determining which of these tyrosine kinase genes is preferentially transcribed in the intestinal crypts. Full length cDNA clones encoding these tyrosine kinases will be isolated and characterized. We will express these cDNAs in cell lines and in transgenic mice, to determine if inappropriate expression results in a detectable phenotype. Antibodies will be generated against fusion proteins encoded by these clones, and these will be used to begin our characterization of the tyrosine kinase proteins. Identification of the tyrosine kinases expressed in the intestine, and isolation of novel crypt cell tyrosine kinase cDNA clones will provide the molecular tools for the genetic and biochemical dissection of differentiation programs taking place in the intestine. Our long-term goal is to understand the function and regulation of crypt cell tyrosine kinases both in vivo and in vitro.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK044525-03
Application #
2143870
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1993-05-01
Project End
1997-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Genetics
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Mathur, Priya S; Gierut, Jessica J; Guzman, Grace et al. (2016) Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer. Mol Cancer Res 14:563-73
Hart, Peter C; Ratti, Bianca A; Mao, Mao et al. (2016) Caveolin-1 regulates cancer cell metabolism via scavenging Nrf2 and suppressing MnSOD-driven glycolysis. Oncotarget 7:308-22
Peng, M; Ball-Kell, S M; Tyner, A L (2015) Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse. Cell Death Dis 6:e1848
Patel, Priyank; Asbach, Benedikt; Shteyn, Elina et al. (2015) Brk/Protein tyrosine kinase 6 phosphorylates p27KIP1, regulating the activity of cyclin D-cyclin-dependent kinase 4. Mol Cell Biol 35:1506-22
Chastkofsky, Michael I; Bie, Wenjun; Ball-Kell, Susan M et al. (2015) Protein Tyrosine Kinase 6 Regulates UVB-Induced Signaling and Tumorigenesis in Mouse Skin. J Invest Dermatol 135:2492-2501
Peng, Maoyu; Emmadi, Rajyasree; Wang, Zebin et al. (2014) PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors. Oncotarget 5:6038-48
Wang, Zebin; Zheng, Yu; Park, Hyun Jung et al. (2013) Targeting FoxM1 effectively retards p53-null lymphoma and sarcoma. Mol Cancer Ther 12:759-67
Zheng, Yu; Tyner, Angela L (2013) Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer. Eur J Clin Invest 43:397-404
Zheng, Yu; Wang, Zebin; Bie, Wenjun et al. (2013) PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer. Cancer Res 73:5426-37
Peng, M; Ball-Kell, S M; Franks, R R et al. (2013) Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models. Oncogenesis 2:e81

Showing the most recent 10 out of 34 publications